Company attributes
B2X
Pitchbook URL
Legal Name
Cerecin Inc.
Number of Employees (Ranges)
11 – 500
Email Address
info@cerecin.com
Full Address
Hvidsværmervej 163B, Rødovre, DK
CIK Number
Founded Date
2001
Total Funding Amount (USD)
189,499,999
Latest Funding Round Date
August 16, 2022
Latest Funding Type
Patents Assigned (Count)
10
Country
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
39,999,999
Published Date
January 1, 1972
Wikidata ID
Overview
Cerecin produces Ketasyn which is a molecule for Alzheimer's, Parkinson's, and other age associated memory impairments. The company was founded by Mark Heiman, Samuel Henderson, and Steve Orndorff in 2001, in Denver, Colorado, United States.
The company looks to understand core molecular and cellular processes that contribute to brain development, plasticity, function, and aging.
As of 2020, Cerecin is developing Tricapilin. Tricapilin is an investigational drug for neurological conditions that is meant to assist with Alzheimer's Disease, migraines, Parkinson's Disease, and epilepsy's.
Some of the companies and partners the company works with includes DCB duchembio, Nestle Health Science, Nestle PURINA, wilmar, and EDB Singapore.
Timeline
No Timeline data yet.
